Press release
Systemic lupus erythematosus (SLE) Market Research Report : Forecast 2025
Download Sample Copy of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2006
Systemic lupus erythematosus (lupus) is an autoimmune disease which is characterized by inflammation of tissue in the body. Immune response is directed toward the body’s own cells, resulting in acute or chronic inflammation. Symptoms of lupus are general and hence often mistaken with symptoms of other diseases. This results in unnoticed progression of disease in the body. The disease is more common in women and usually affects individuals in the age group of 25 to 45. Although the main cause of the disease is unknown, it is linked to genetic and hormonal factors. In several instances, drug-induced lupus erythematosus is also observed commonly against drugs such as isoniazid, hydralazine, and procainamide. The diagnosis of systemic lupus erythematosus is based on distinctive clinical findings of the skin, kidneys, joints, the central nervous system, as well as on serological parameters such as antinuclear antibodies (ANA). Common symptoms include fever, fatigue, and arthralgia occurring at disease onset. Joint swelling or a butterfly rash observed particularly in women of childbearing age indicates the development of systemic lupus erythematosus (SLE).
The prevalence of lupus is higher in Europe and Australia as compared to North America. In North America, the disease is more prevalent among Hispanics, Asians, and Native Americans, according to Centers for Disease Control and Prevention (CDC). Currently no cure for lupus exists, but the disease is treated with immunosuppressants, anti-inflammatory drugs, and intravenous immunoglobulins. GlaxoSmithKline plc manufactured Benlysta (belimumab) is a B lymphocyte stimulator, which received FDA approval in 2011 for treatment of lupus. Ibuprofen and aspirin are widely prescribed anti-inflammatory drugs for suppressing symptoms of lupus. Immunosuppressants such as CellCept (Mycophenolatemofetil) by Roche, Neoral (Cyclosporine) by Novartis AG, and Imuran (Azathioprine) by GlaxoSmithKline plc are also commonly prescribed for lupus treatment.
The global systemic lupus erythematosus market is witnessing significant growth due to rising prevalence of the disease, medical advancements in the treatment of systemic lupus erythematosus or SLE, extensive research activities, and rising awareness among people about SLE treatments. The systemic lupus erythematosus market can be categorized on the basis of drug class and region. On the basis of drug class, the market can be segmented into non-steroidal anti-inflammatory drugs (NSAIDs), anti-malarial agents, corticosteroids and immunosuppressants. On the basis of geography, the market is segmented into five regions, namely North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
View Report @ http://www.transparencymarketresearch.com/systemic-lupus-erythematosus-market.html
Some of the key players operating in the systemic lupus erythematosus (SLE) market include Aurinia Pharmaceuticals Inc., Bristol-Myers Squibb Company, Cadila Healthcare, GlaxoSmithKline plc, ImmuPharma plc, Mylan N.V., F. Hoffmann-La Roche AG, and Sandoz International GmbH (Novartis AG).
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Systemic lupus erythematosus (SLE) Market Research Report : Forecast 2025 here
News-ID: 523227 • Views: …
More Releases from Transparency Market Research
Transformer Dismantling & Recycling Services Market Outlook 2034: How Sustainabl …
As global energy systems evolve and electricity demand rises, the safe, efficient, and environmentally responsible disposal of aging electrical infrastructure has become an urgent priority. Transformers-critical components of transmission and distribution networks-must be replaced or refurbished regularly due to wear, efficiency loss, safety concerns, or regulatory mandates. Transformer dismantling and recycling services play a vital role in ensuring that these large, complex electrical units are decommissioned safely while valuable materials…
Online Dating Services Market Outlook 2034: How Digital Matchmaking Platforms Ar …
The online dating services market has undergone a remarkable transformation over the past decade, evolving from simple matchmaking websites to highly intelligent, data-driven platforms that use artificial intelligence, behavioral insights, and preference-based algorithms to match users more effectively. The rise of mobile apps, digital socialization, and increased acceptance of online dating across age groups has made digital matchmaking a mainstream phenomenon. In 2023, the global online dating services market was…
Ambulatory Infusion Centers Market Outlook 2035: Transforming Outpatient Care Th …
Ambulatory infusion centers (AICs) have become one of the most rapidly expanding components of modern healthcare, driven by a growing emphasis on outpatient care solutions, the rising prevalence of chronic diseases, and increasing adoption of advanced biologics. These specialized centers provide infusion therapies outside of hospital settings, offering patients convenience, affordability, and improved treatment experiences. As healthcare systems worldwide shift toward models that prioritize cost savings, patient comfort, and efficient…
Amyloidosis Therapeutics Market Outlook 2035: Advancements in Rare Disease Treat …
The global healthcare landscape is witnessing a growing focus on rare diseases, propelled by increasing awareness, expanded diagnostic capabilities, and advancements in personalized medicine. Amyloidosis, a group of rare but severe conditions caused by the buildup of abnormal amyloid proteins in tissues and organs, has moved into the spotlight as medical science uncovers more effective treatments and diagnostic tools. The amyloidosis therapeutics market, valued at US$ 2.7 billion in 2024,…
More Releases for SLE
Systemic Lupus Erythematosus (SLE) Market Detailed Industry Report Analysis 2025 …
Introduction
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease where the immune system attacks multiple organ systems, including skin, joints, kidneys, and blood vessels. It is often unpredictable, with flare-ups and remissions that complicate management. Symptoms range from fatigue and skin rashes to life-threatening organ damage.
While conventional treatments such as corticosteroids, antimalarials, and immunosuppressants remain central, recent years have seen significant advances with biologics, targeted therapies, and precision medicine approaches.…
Systemic Lupus Erythematous SLE Drugs Market Professional Survey Report 2015-202 …
Systemic Lupus Erythematous (SLE) is a chronic autoimmune disease which causes the immune system to mistakenly attack health body tissue. In SLE, body immune system can affect any part of the body, such as joints, organs, eyes, skin, etc. Often SLE can result in symptoms such as malar rash, discoid lesions, sub-acute cutaneous lesions, photosensitivity, oral ulcers, arthritis, serositis, nephropathy, neurologic involvement, thrombocytopenia, haemolytic anemia, fever, Raynaud’s phenomenon, livedo reticularis,…
Systemic lupus erythematosus (SLE) Market: Analysis and Segment Forecasts To 20 …
Systemic lupus erythematosus (lupus) is an autoimmune disease which is characterized by inflammation of tissue in the body. Immune response is directed toward the body’s own cells, resulting in acute or chronic inflammation. Symptoms of lupus are general and hence often mistaken with symptoms of other diseases. This results in unnoticed progression of disease in the body. The disease is more common in women and usually affects individuals in the…
Systemic lupus erythematosus (SLE) Market Report by Regional Analysis : forecast …
Systemic lupus erythematosus (lupus) is an autoimmune disease which is characterized by inflammation of tissue in the body. Immune response is directed toward the body’s own cells, resulting in acute or chronic inflammation. Symptoms of lupus are general and hence often mistaken with symptoms of other diseases. This results in unnoticed progression of disease in the body. The disease is more common in women and usually affects individuals in the…
Global Resuscitation Ventilators Market 2017 : Eternity, SIRIUSMED, Siare & SLE
The survey report by Market Research Store is an overview of the global Resuscitation Ventilators market. It covers all the recent trends including key developments in the global market in present and in future. Analyses of the global Resuscitation Ventilators market trends along with the projections of CAGRs (compound annual growth rates) are provided in the research report.
Further, an evaluation of the history of the global market and the basic…
Global Respiratory Devices Market-SLE Ltd, Teijin Pharma, Resmed, Weinmann
Global Respiratory Devices Market report 2017 is an in-depth research on the current situation of the Respiratory Devices industry.
The Scope of the Respiratory Devices research report:
The Global Respiratory Devices Market primarily includes a basic overview of the Respiratory Devices industry. It also includes Respiratory Devices definitions, classifications and applications. It segments the market by applications, types, regions, competitive players and also analyzes Respiratory Devices market size, business share and Respiratory…
